Chargement en cours...
The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, and the majority of NSCLC patients are diagnosed at the advanced stage. Chemotherapy is still the main treatment at present, and the overall prognosis is poor. In recent years, immunotherapy has developed rapidly....
Enregistré dans:
| Publié dans: | Biomed Res Int |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984892/ https://ncbi.nlm.nih.gov/pubmed/33791360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/1780860 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|